|
1
|
Chapiro J, Duran R, Lin MD, Schernthaner
RE, Wang Z, Gorodetski B and Geschwind JF: Identifying staging
markers for hepatocellular carcinoma before transarterial
chemoembolization: Comparison of three-dimensional quantitative
versus non-three-dimensional imaging markers. Radiology.
275:438–447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang XJ, Zhang AH and Sun H: Power of
metabolomics in diagnosis and biomarker discovery of hepatocellular
carcinoma. Hepatology. 57:2072–2077. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang WY and Wei C: Advances in the early
diagnosis of hepatocellular carcinoma. Genes Dis. 7:308–319. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tabrizian P, Jibara G, Shrager B, Schwartz
M and Roayaie S: Recurrence of hepatocellular cancer after
resection: Patterns, treatments, and prognosis. Ann Surg.
261:947–955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Wu G, Li J, Wang Y, Ju X and Jiang
W: lncRNA CRNDE promotes the proliferation and metastasis by acting
as sponge miR-539-5p to regulate POU2F1 expression in HCC. BMC
Cancer. 20:2822020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsumoto-Taniura N, Pirollet F, Monroe R,
Gerace L and Westendorf JM: Identification of novel M phase
phosphoproteins by expression cloning. Mol Biol Cell. 7:1455–1469.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Li Z, Ruan J, Xu C, Tong Y, Pan PW,
Tempel W, Crombet L, Min J and Zang J: Structural basis for
specific binding of human MPP8 chromodomain to histone H3
methylated at lysine 9. PLoS One. 6:e251042011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tchasovnikarova IA, Timms RT, Matheson NJ,
Wals K, Antrobus R, Göttgens B, Dougan G, Dawson MA and Lehner PJ:
GENE SILENCING. Epigenetic silencing by the HUSH complex mediates
position-effect variegation in human cells. Science. 348:1481–1485.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kokura K, Sun LD, Bedford MT and Fang J:
Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing
and promotes tumour cell motility and invasion. EMBO J.
29:3673–3687. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao XY, Qiao YL, Zhang Y, Wang J, Shen X
and Xu CW: Knockdown of MPP8 suppresses cell proliferation via
regulation of HOXA5 in non-small cell lung cancer cells. Cell Mol
Biol (Noisy-le-grand). 64:27–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu JG, Yan PY, Zhao XM, Xing C, Wang L,
Wang X and Wang2 X: Mechanism of MPP8 in the regulating of growth
and metastasis of gastric cancer by P53/BCL-2 signaling pathway and
emt. Acta Med Mediterr. 35:1331–1335. 2019.
|
|
12
|
Wang Y, Xiao H, Wang C, Wu H, He H, Yao C,
Cui J and Li W: M-phase phosphoprotein 8 promotes gastric cancer
growth and metastasis via p53/Bcl-2 and EMT-related signaling
pathways. J Cell Biochem. 121:2330–2342. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan B, Lin L, Ying ZY, Ying MX, Zhou QY
and Shi L: Repression of M-phase phosphoprotein 8 inhibits melanoma
growth and metastasis in vitro and in vivo. Int J Clin Exp Pathol.
10:12003–12009. 2017.PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song Y, Jin X, Liu Y, Wang S, Bian F, Zhao
Q, Shi H and Gao Z: Long noncoding RNA ZFPM2-AS1 promotes the
proliferation, migration, and invasion of hepatocellular carcinoma
cells by regulating the miR-576-3p/HIF-1α axis. Anticancer Drugs.
32:812–821. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun EJ, Wankell M, Palamuthusingam P,
McFarlane C and Hebbard L: Targeting the PI3K/Akt/mTOR pathway in
hepatocellular carcinoma. Biomedicines. 9:16392021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Downward J: PI 3-kinase, Akt and cell
survival. Semin Cell Dev Biol. 15:177–182. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chandrashekar DS, Karthikeyan SK, Korla
PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne
U, et al: UALCAN: An update to the integrated cancer data analysis
platform. Neoplasia. 25:18–27. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen YH and Wang XW: miRDB: An online
database for prediction of functional microRNA targets. Nucleic
Acids Res. 48(D1): D127–D131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lou Z, Gong YQ, Zhou X and Hu GH: Low
expression of miR-199 in hepatocellular carcinoma contributes to
tumor cell hyper-proliferation by negatively suppressing XBP1.
Oncol Lett. 16:6531–6539. 2018.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Wen X, Liu B, Zhang Q, Zhang J,
Miao H and Zhu R: Diosmetin inhibits the metastasis of
hepatocellular carcinoma cells by downregulating the expression
levels of MMP-2 and MMP-9. Mol Med Rep. 13:2401–2408. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mazzaferro V, Regalia E, Doci R, Andreola
S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A and
Gennari L: Liver transplantation for the treatment of small
hepatocellular carcinomas in patients with cirrhosis. N Engl J Med.
334:693–699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kudo M, Trevisani F, Abou-Alfa GK and
Rimassa L: Hepatocellular carcinoma: Therapeutic guidelines and
medical treatment. Liver Cancer. 6:16–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murata K, Sato S, Haruta M, Goshima T,
Chiba Y, Takahashi S, Sharif J, Koseki H, Nakanishi M and Shimada
M: Physical interaction between MPP8 and PRC1 complex and its
implication for regulation of spermatogenesis. Biochem Biophys Res
Commun. 458:470–475. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lau MT, Klausen C and Leung PCK:
E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt
signaling via β-catenin-Egr1-mediated PTEN expression. Oncogene.
30:2753–2766. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu XM, Zhang Q, Deng QF and Li Q:
Circular RNA hsa_circ_0012673 promotes breast cancer progression
via miR-576-3p/SOX4 axis. Mol Biotechnol. 65:61–71. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li H, Cao B, Zhao R, Li T, Xu X, Cui H,
Deng H, Gao J and Wei B: circDNMT1 promotes malignant progression
of gastric cancer through targeting miR-576-3p/hypoxia inducible
factor-1 alpha axis. Front Oncol. 12:8171922022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang Z, Li SQ, Xu X, Xu X, Wang X, Wu J,
Zhu Y, Hu Z, Lin Y, Mao Y, et al: MicroRNA-576-3p inhibits
proliferation in bladder cancer cells by targeting cyclin D1. Mol
Cells. 38:130–137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Greenawalt EJ, Edmonds MD, Jain N, Adams
CM, Mitra R and Eischen CM: Targeting of SGK1 by miR-576-3p
inhibits lung adenocarcinoma migration and invasion. Mol Cancer
Res. 17:289–298. 2019. View Article : Google Scholar : PubMed/NCBI
|
